Found 25 matching trials
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement PHASE2 This is an open-label, multinational, randomized Phase 2 study confirming t...
Show More Location
University of California San Diego UCSD - Moores Cancer Center
Learn More & Join Trial
Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial PHASE2 This phase II trial tests the safety and effectiveness of preoperative immu...
Show More Location
Northwestern University
Learn More & Join Trial
A Study of TAS-120 in Patients With Metastatic Breast Cancer PHASE2 The purpose of the trial is to evaluate a patient's response to a Fibroblas...
Show More Learn More & Join Trial
A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) PHASE2 The global objective of this Basket of Basket study is to evaluate the anti...
Show More Location
Institut Gustave Roussy
Learn More & Join Trial
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma PHASE2 It's propose this pilot phase 2 study to explore the combination therapy of...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Futibatinib in Patients With Specific FGFR Aberrations PHASE2 The purpose of this study is to evaluate the efficacy and safety of futibat...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Personalized Medicine for Advanced Biliary Cancer Patients PHASE3 The object of this trial is to evaluate whether the introduction of a targe...
Show More Location
Cliniques universitaires de Bruxelles - Hôpital Erasme ULB
Learn More & Join Trial
Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma PHASE2 The purpose of the trial is to evaluate the antitumor activity and confirm ...
Show More Location
UCSF Helen Diller Family Comprehensive Cancer Center
Learn More & Join Trial
Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma PHASE1 This phase I trial tests the safety, side effects and best dose of futibati...
Show More Location
Northwestern University
Learn More & Join Trial
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors PHASE2 This is a nonrandomized, uncontrolled, open-label, multicenter Phase 2 stud...
Show More Status
Active Not Recruiting
Location
University of California Los Angeles UCLA - Cancer Care - Santa Monica
Learn More & Join Trial